ICU Medical Inc (NASDAQ: ICUI) is a medical device company that develops, manufactures, and sells infusion therapy, oncology, and critical care products used in hospitals and clinical settings. Revenue is transactional, generated through the sale of disposable and capital equipment products to healthcare providers. The 10-K filed 2026-02-19 (accession 000088398426000008) covers the fiscal year ended in that reporting period. The filing confirms ICU Medical operates across infusion systems, IV solutions, and related consumables, selling primarily into acute care hospitals. The company is incorporated and headquartered in the United States. Specific segment revenue breakdowns, customer concentration figures, competitor names, geographic revenue splits, founding year, and current CEO tenure are not supported by the excerpts provided in this filing and are therefore omitted.

Revenue model

Transactional sales of disposable medical devices and capital equipment to healthcare providers, primarily hospitals.

Products and services

Infusion therapy products, oncology products, critical care products, IV solutions, infusion systems, and related consumables.

Customers and end markets

Acute care hospitals and clinical healthcare providers.

Value-chain role

Medical device manufacturer and direct supplier to healthcare providers.

Geographic exposure

United States; international exposure not detailed in provided excerpts.

Source: SEC 10-K, filed 2026-02-19

Industry: Surgical & Medical Instruments & Apparatus Peers: Embecta Corp Cooper Companies Inc QuidelOrtho Corp DENTSPLY SIRONA Inc Haemonetics Corp Lantheus Holdings Inc Merit Medical Systems Inc Neogen Corp STAAR Surgical Co